We are live on ! Find out more
GSKH

GSK PLC ADRhedged
GSKH

2 hedge funds and large institutions have $296 invested in GSK PLC ADRhedged in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

284% more capital invested

Capital invested by funds: $77 → $296 (+$219)

100% more funds holding

Funds holding: 1 → 2 (+1)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$223

Top Sellers

No sellers this quarter

GSKH Hedge Fund Activity: Q2 2026 in Review

2 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in GSK PLC ADRhedged (GSKH) for Q2 2026, worth a combined $296 — up 284% from $77 a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new GSKH positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $223.

  • 2 institutional investors held GSK PLC ADRhedged (GSKH) as of Q2 2026, up from 1 in Q1 2026.
  • Funds reported $296 of GSK PLC ADRhedged stock for Q2 2026, up 284% quarter-over-quarter.
  • 1 fund opened new GSK PLC ADRhedged positions in Q2 2026 and 0 closed out, a net change of +1 holder.
  • The largest GSK PLC ADRhedged buyer in Q2 2026 was UBS Group, an estimated $223 added.

Based on aggregated 13F filings for Q2 2026.